74. PE and DVT Flashcards
(108 cards)
<span>while PE and DVT can occur in any age group, older patients have a much higher incidence, at 1/10,000 in people 20 to 30 years old and 1/100 in people greater than 80 years old.</span>
P<span>E and DVT are frequently on the differential diagnosis for patients who present with chest pain, dyspnea, syncope, tachycardia, hypoxemia, leg pain, edema, and other nonspecific complaints. </span>
<span>venous thrombosis occurs when the propensity of blood to coagulate overwhelms endogenous anticoagulant and fibrinolytic systems</span>
<span>Numerous factors associated with the classic triad of venous injury, venous stasis, and hypercoagulability have been associated with an increased risk of VTE in epidemiologic studies</span>
<span>might increase a patient’s propensity to clot and should consider these factors when determining whether a patient’s clinical presentation warrants an evaluation for VTE. Important factors include older age, prior history of VTE, active cancer, recent surgery or trauma, recent hospitalization longer than three days, limb immobility, and estrogen use (especially if initiated in the past three months).</span>
<span>As many as 50% of patients diagnosed with PE have no apparent clinical risk factors for PE or DVT at the time of diagnosis. </span>
<span>The superficial venous system consists primarily of the greater and short saphenous veins and perforating veins.</span>
<span>Distal greater saphenous vein thrombi are often referred to as superficial thrombosis, but greater saphenous clots near the connection with the femoral vein should be referred to as DVT. </span>
<span>he deep venous system includes the anterior tibial, posterior tibial, and peroneal veins, collectively called the calf veins.</span>
<span>he calf veins join together at the knee to form the popliteal vein, which extends proximally and becomes the femoral vein at the adductor canal. Venous thrombi in the popliteal or more proximal veins are referred to as proximal DVT. T</span>
<span>The femoral vein (previously known as the superficial femoral vein), is joined by the deep femoral vein and then the greater saphenous vein to form the common femoral vein, which subsequently becomes the external iliac vein at the inguinal ligament. Venous thrombi in the proximal femoral and iliac veins are known as iliofemoral DVT.</span>
<img></img>
<span>Compression ultrasound, including point-of-care ultrasound, is typically limited to the common femoral, femoral, and sometimes popliteal veins.</span>
<span>DVT formation typically begins when monocytes expose blood to tissue factor on their surfaces. This process overwhelms natural anticoagulant and fibrinolytic mechanisms and leads to the aggregation of red blood cells, platelets, and fibrin in the venous sinuses or cusps of the lower extremity deep veins. </span>
<span>A PE can be described as saddle if the clot is visualized across the bifurcation of the main right and left pulmonary arteries </span>
<img></img>
<span> Increased right ventricular (RV) afterload (i.e., when the pulmonary artery systolic pressure exceeds 40 mm Hg) can lead the thin-walled right ventricle to dilate and become hypokinetic. </span>
<img></img>
<span>More than 90% of upper extremity DVT occur in the presence of an indwelling catheter or similar device.</span>
<span>In the absence of a device, upper extremity DVT tends to occur in the dominant arm of young athletes, a condition known as Paget-Schroetter syndrome. Paget-Schroetter syndrome is an effort-induced form of thoracic outlet syndrome</span>
UE DVT <span>Repetitive motion of the arm in the setting of hypertrophied scalene muscles or congenital cervical ribs causes compression of the subclavian vein and DVT.</span>
DDX dvt
<ul><li><div>Venous insufficiency causing congestion and inflammation</div></li><li><div>Cellulitis</div></li><li><div>Muscle or tendon injury</div></li><li><div>Baker cyst (including ruptured synovial membrane)</div></li><li><div>Hematoma</div></li><li><div>Arterial insufficiency and claudication</div></li><li><div>Asymmetrical edema (e.g., due to congestive heart failure or liver disease)</div></li></ul>
<img></img>
<span>The Wells DVT score has not been validated in pregnant women, but the LEFt score has been validated in a study of 157 pregnant women. It consists of 1 point in case of left ( </span><i>L</i><span> ) leg suspicion, 1 point for edema ( </span><i>E</i><span> ), and 1 point if the suspicion occurred during the first trimester ( </span><i>Ft</i><span> ) of pregnancy. A LEFt score of 0 or 1 indicates low PTP. Although not validated, an approach that substitutes the LEFt score for the Wells score in pregnant women is reasonable.</span>
- Female sex
- • Advanced age
- • Black or African American race
- • Cocaine use
- • Immobility (general, limb, or neurologic)
- • Hemoptysis
- • Hemodialysis
- • Malignancy (active)
- • Rheumatologic disease (rheumatoid arthritis, systemic lupus erythematosus)
- • Sickle cell disease
- • Pregnancy and postpartum state
- • Recent surgery (within 1 month)



- • Active bleeding into a critical organ or uncontrolled site
- • Severe bleeding diathesis
- • Recent, planned, or emergency high-bleeding-risk surgery or procedure
- • Recent major trauma
- • Recent intracranial, spinal or ocular hemorrhage
- •
- • History of gastrointestinal major bleeding
- • Intracranial or spinal tumors
- • Previous bleeding into a tumor
- • Large abdominal aortic aneurysm with concurrent severe hypertension
- • Stable aortic dissection
- • Recent, planned, or emergent low-bleeding-risk surgery/procedure
- •
- • Active cancer, 2 points
- • Male patient with uncontrolled hypertension, 1 point
- • Anemia, 1.5 points
- • History of bleeding, 1.5 points
- • Renal dysfunction (creatinine clearance 30–60 mL/min), 1.5 points
- • Age ≥60 years, 1.5 points





If the administration of intravenous fluids is contraindicated or no longer beneficial, vasopressors should be administered, and norepinephrine should be the initial agent in blood pressure support. 12 Dobutamine is useful as an adjunct but may worsen hypotension unless coadministered with norepinephrine.
Extracorporeal membrane oxygenation (ECMO) can unload the right ventricle, increase cardiac output, and provide a bridge to thrombolysis or thromboembolectomy for patients with high-risk PE. 54 ECMO requires institutional infrastructure and expertise which is only available in specialized centers. Survival of patients with PE who require ECMO is about 70%. 54 , 55
Appropriate regimens for full-dose thrombolysis include alteplase (recombinant tissue plasminogen activator, rtPA) given as a 100-mg IV bolus over two hours, reteplase given as 10 units IV over two minutes and then repeated 30 minutes later, and tenecteplase given as a single weight-based bolus dose over 5 to 10 seconds. Practically speaking, two IV boluses of 50 mg separated by 15 minutes may be more realistic than a two-hour infusion of alteplase for an unstable patient.
- • Systolic blood pressure > 100 mm Hg
- • No thrombolysis needed
- • No active bleeding
- • Oxygen required to maintain oxygen saturation > 94%
- • Not already anticoagulated
- • Absence of severe pain requiring > two doses of intravenous narcotics
- • Other medical or social reasons to admit
- • Creatinine clearance > 30 mL/min
- • Not pregnant, severe liver disease, or heparin-induced thrombocytopenia





opioids
simple asphyxiants
co
historic hypoxia with confusion/seizure/collapse/H sulfide smells like rotten eggs, cyanid (bitter almond smell)
methemoglobinemia
toxic alcs
inhalants
psych meds with wide qrs
anticonvulsants
anticholi
clonidine
beta blocker
salicyclates
NMS
Serosyndr
cortical infarct
cerebellar infarct
basilar a occlusion